
The company has launched the product, which is a generic version of Teijin Ltd's Uloric tablets, after getting approval from the US Food and Drug Administration (USFDA), the company said in a regulatory filing.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3i337VJ
via
IFTTT
0 comments:
Post a Comment